topstockalerts
Nov 9, 11:17 PM
JBS reported a disappointing third-quarter 2026 performance, missing Wall Street expectations across most key profitability metrics. Net income attributable to the company plunged 72% year over year to
$164 million, while adjusted IFRS EBITDA fell 36% to
$1.181 billion, below analysts’ consensus of approximately
$1.32 billion. Reported EPS came in at
$0.15, less than half the
$0.32 expected, extending a series of earnings disappointments that had already driven analysts to cut EPS estimates by nearly 32% over the previous two months.
Cash generation also deteriorated significantly, with free cash flow turning negative at
$167 million, reflecting weaker profitability and higher inventories associated with China's 2027 import quota cycle. Net leverage increased to 3.54x from 2.39x a year earlier, raising concerns about the company's balance sheet and financial flexibility amid challenging global meat prices and compressed industry margins.
$JBS
